BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8585725)

  • 1. Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.
    Tisdale M; Ellis M; Klumpp K; Court S; Ford M
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2454-8. PubMed ID: 8585725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
    Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.
    Price PM; Banerjee R; Jeffrey AM; Acs G
    Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antiviral agent which inhibits the endonuclease of influenza viruses.
    Tomassini JE; Davies ME; Hastings JC; Lingham R; Mojena M; Raghoobar SL; Singh SB; Tkacz JS; Goetz MA
    Antimicrob Agents Chemother; 1996 May; 40(5):1189-93. PubMed ID: 8723464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of initiating nucleoside triphosphate concentrations in the regulation of influenza virus replication and transcription.
    Vreede FT; Gifford H; Brownlee GG
    J Virol; 2008 Jul; 82(14):6902-10. PubMed ID: 18463155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12].
    Markushin SG; Sinitsyn BV; Ginzburg VP; Khaĭder AM; Klimov AI
    Vopr Virusol; 1993; 38(3):122-6. PubMed ID: 8073750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
    Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
    Huang Q; Zhong Y; Li J; Ye Y; Wu W; Chen L; Feng M; Yang J; Liu S
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1143-1149. PubMed ID: 32327257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of synthesis of virus-specific RNA in cells infected with influenza virus].
    Varich NL; Gubareva LV; Kaverin NV
    Mol Gen Mikrobiol Virusol; 1988 Nov; (11):35-40. PubMed ID: 3237235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.
    Kane EM; Shuman S
    J Virol; 1995 Oct; 69(10):6352-8. PubMed ID: 7666536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
    Davis AM; Ramirez J; Newcomb LL
    Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative anti-influenza virus activity of 2'-deoxy-2'-fluororibosides in vitro.
    Rollins BS; Elkhatieb AH; Hayden FG
    Antiviral Res; 1993 Aug; 21(4):357-68. PubMed ID: 8215305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation properties of vaccinia virus RNA polymerase: pausing, slippage, 3' end addition, and termination site choice.
    Deng L; Shuman S
    Biochemistry; 1997 Dec; 36(50):15892-9. PubMed ID: 9398322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets.
    Jakeman KJ; Tisdale M; Russell S; Leone A; Sweet C
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1864-7. PubMed ID: 7986023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes.
    Cai W; Li Y; Chen S; Wang M; Zhang A; Zhou H; Chen H; Jin M
    Antiviral Res; 2015 Jun; 118():82-92. PubMed ID: 25800824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus.
    Kurokawa M; Ochiai H; Nakajima K; Niwayama S
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2149-55. PubMed ID: 1698925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo.
    Crescenzo-Chaigne B; Naffakh N; van der Werf S
    Virology; 1999 Dec; 265(2):342-53. PubMed ID: 10600605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of fowl plague virus RNA synthesis in temperature-sensitive mutants.
    Ghendon YZ; Markushin SG; Blagovezhenskaya OV; Genkina DB
    Virology; 1975 Aug; 66(2):454-63. PubMed ID: 1171553
    [No Abstract]   [Full Text] [Related]  

  • 20. On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride.
    Skehel JJ; Hay AJ; Armstrong JA
    J Gen Virol; 1978 Jan; 38(1):97-110. PubMed ID: 563896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.